
Delivering Uncommon Results · Sell-Side M&A for Medical Aesthetic Practices
You'll Sell This Once. They Do It Every Week.
A private-equity buyer shows up with a term sheet built by a full deal team, and a playbook sharpened on deal after deal. A single-buyer process hands you a number built for their advantage, not yours. We run a confidential, competitive sale exclusively for medical aesthetic practices, so the right buyers compete on your terms.
Before You Talk To Any Buyer
Most owners leave money on the table, not because the market is bad, but because they sell to the wrong buyer.
The first buyer who approaches you is almost never the best buyer. A single-buyer process produces a single offer, and that offer reflects what is convenient for that buyer, not what your practice is worth in a competitive process.
Owners who go to market without an advisor who knows this industry often find out what they didn’t know the hard way, mid-negotiation, when the cost of not knowing is highest. Generalist M&A brokers do not know your buyer pool. They do not know which private-equity groups are actively building medical-aesthetic platforms in your market right now. They do not know what patient-retention metrics your acquirer will discount, or what your injector tenure is worth to a strategic buyer. We do.
"I met with a business broker who didn't know med spas, and I could tell right away... this would not be a good situation."
Julie Davis, owner, Pura Vida Body & Mind Spa
See Your Number First
Know your number before anyone else does.
A confidential ballpark in under two minutes. No email required to see your range. The estimate is generated on your device. Nothing is stored or sent unless you choose to continue.
Step 1 · Instant ballpark
Estimated enterprise value
Practices like yours trade around 2.6x – 5.3x adjusted earnings.
What raises your number
- Build recurring revenue past 30% of sales
- Reduce owner-performed treatment dependence
- Clean, normalized three-year financials
What lowers your number
- Owner performs the majority of clinical work
- Recurring revenue under 15% of sales
Step 2 · What you receive when you continue
Your custom valuation report. Comparable transactions, your likely buyer pool, and timing analysis.
Your buyer-readiness scorecard. The specific moves that raise your multiple before you go to market.
A confidential 30-minute strategy call with Bill Walker. No obligation, no pressure.
Your information is never shared, and we have never broken a client's confidentiality.
Estimate only. A ballpark from limited inputs plus published industry M&A benchmarks.
Medical Practices We Serve
Eight verticals. One sell-side specialist.
Most advisors generalize. We go deep on the practice types where aesthetic and cash-pay economics actually drive the multiple, and we don't value what we can't comp.
Medical Spas
Recurring-revenue and membership economics that command premium multiples.
View specialistCosmetic Dermatology
Cash-pay procedure mix and provider retention drive buyer appetite.
View specialistPlastic & Cosmetic Surgery
Separating personal goodwill from transferable practice value.
View specialistAmbulatory Infusion Centers
Drug-mix to multiple framework, modeled on our own comps.
View specialistWomen's Health
Aesthetic-adjacent OB-GYN and wellness with cash-pay upside.
View specialistRegenerative & Wellness
Longevity and GLP-1 momentum, valued only against real comps.
View specialistCosmetic & Specialty Dentistry
High-margin elective dentistry inside the aesthetic wedge.
View specialistEndocrinology
Riding GLP-1 and longevity demand, comped honestly.
View specialistThe Side Of The Table You're Actually On
An uncommon desk for an uncommon sale
Aesthetic Brokers' verified transaction figures (capital guided, practices advised, average uplift versus inbound offers) are shared under NDA in your confidential consultation. We publish no number we cannot stand behind.
Represented vs. Unrepresented
An unrepresented offer is rarely your best offer.
The first offer is the number a buyer believes will get you to say yes before anyone else is at the table. A single inbound buyer with no competition has every reason to anchor low. A confidential, competitive process changes who holds the advantage, and what your practice is worth when the deal is done.
Illustrative comparison. Specific figures come from Aesthetic Brokers' own verified deal data with cited methodology, shared in your confidential consultation. No invented numbers.
Range, never a promise. Your real number depends on your economics, which a confidential review maps precisely. In one engagement, a competitive process beat the off-market offer the owner had almost accepted by a wide margin.
Founder briefing The Briefing Room
Founder authority, on every deal.
Aesthetic Brokers was founded by Bill Walker after a career on the buy side of private-equity-backed healthcare, where he watched practice owners go underserved in the single most important transaction of their professional lives. He built the firm to sit on one side of the table only. Yours.
Marine Corps aviator turned M&A advisor. Served at the Presidential Helicopter Squadron under two administrations and commanded a squadron in combat before leading healthcare M&A.
Buy-side perspective, sell-side allegiance. Led acquisitions for a private-equity-backed healthcare organization, so he knows exactly how investors value a practice and where the value is won or lost.
Harvard Kennedy School and Georgetown McDonough. Graduate training in government and business, applied to one mission: outsized outcomes for aesthetic practice owners.
Track Record · Anonymized
Proof, without the breach.
Confidentiality is the product. These are real transaction shapes with identifying detail redacted, the same discretion we extend to your deal.

Tombstone values redacted by design. The published board uses Aesthetic Brokers' verified, client-consented anonymized deals only.
Our Method
Four moves. One outcome.
Every valuation starts on the concrete foundation of your real net income, then builds the multiple up from what buyers actually pay for: durable cash flow, capacity to grow, and a service mix that is diversified rather than dependent on you.

Identify Your Options
A confidential, no-obligation review of your size, scope, and goals against the market. You leave understanding your value range and your realistic paths, not a guess.
Prepare to Go to Market
We normalize earnings so your true profitability is visible, and resolve gaps before a buyer's accounting team runs a quality-of-earnings review.
Connect the Right Fit
We bring a competitive market of vetted private equity, family offices, and strategics to your doorstep, so buyers compete instead of anchoring against you.
Maximize Your Outcome
We negotiate structure, rollover equity, and transition so the number on paper becomes the number in your pocket, and your legacy is protected through close.
Our Services
Three ways we work, all on your side of the table.
Whether you are ready to go to market now, a few years out, or already holding a letter of intent, we represent you and only you.
Sell-Side Advisory
We represent practice owners exclusively. No dual agency, ever. We run a confidential, competitive process to find the buyer who pays the most for what you have built.
Growth Consulting
You are one to three years from a sale. We help you close the gaps that hold your multiple back: injector stability, recurring revenue, clean financials, lease terms. Owners who do this work first sell for more.
Due Diligence Support
You have a letter of intent in hand and the buyer's team is in your financials. We sit on your side of the table through due diligence so the adjustments go in your favor, not theirs.
Straight Answers
What owners ask before they commit to anything.
Your practice is valued on its adjusted EBITDA, not its revenue. We normalize earnings, adding back owner compensation above market and one-time expenses, then apply a market multiple shaped by owner concentration, recurring revenue, and operational maturity. Most buyers underwrite this through a discounted cash flow and quality-of-earnings lens, so we model your practice the same way they will, before they do.
It means we represent only you, the seller, and never the buyer in the same deal. Every aesthetic practice transaction we run is built around one objective: maximizing your outcome. Buyers, including private equity groups, have their own advisors and their own playbook. Sell-side-exclusive representation puts an experienced team on your side of the table so your interests are the only ones we protect.
Yes. Confidentiality is how we protect your practice’s value, not just your privacy. Premature word of a sale can damage staff morale, patient confidence, and ultimately your sale price. We use strict confidentiality agreements, secure data rooms, and a screened buyer process so your information reaches only serious, qualified parties, and only on your timeline.
We maximize value two ways: preparation and competition. First, we surface what a buyer’s diligence team will find, such as owner concentration, add-backs, and compliance gaps, early enough for you to act on it. Then we run a competitive process so multiple qualified buyers compete for your practice instead of you accepting a single offer. The first offer is rarely the best offer.
Our compensation is built primarily around a success fee, so we are paid when your transaction closes and our incentive is aligned with maximizing your outcome. Some engagements include a retainer or upfront fee in addition to the success fee. Exact terms are defined in a clear engagement agreement before any work begins, with no surprises.
Start 12 to 24 months before you intend to go to market. That window is what lets the analysis actually work for you: reducing owner concentration takes time, compliance issues take time to remediate, and recurring-revenue programs need time to show up as a pattern in your financials. Starting early is the single biggest lever you control over your final number.
We have completed transactions across a wide range of sizes, from small single-provider practices to multi-million-dollar groups. The more important question is whether your practice has recurring revenue, a loyal patient base, and a clean P&L. Those three factors move a multiple more than size alone. If you are unsure, use the estimator above. It will show your likely range in about a minute.
Good. Most of our best transactions start 12 to 24 months before the owner is ready to close. The reason is that buyer-readiness work, cleaning up your lease terms, stabilizing your injector team, and organizing your financials, can add a meaningful premium to your final multiple. We offer a no-cost Growth Consulting engagement to owners who are one to three years out from a sale. There is no pressure and no commitment.
The Next Step
Your practice deserves an uncommon partner.
Start with a two-minute, confidential read on where you stand, with no obligation and nothing stored.